The Global Anxiety Disorder and Depression Treatment Market size is forecast to reach USD 19.53 Billion by 2028, registering a CAGR of 2.4% over the forecast period, according to a new report by Reports and Data. Major factors driving market revenue growth are increasing awareness about mental health disorders and the rising demand to treat such disorders as anxiety and depression.
Anxiety disorders and depression, are among the most prevalent mental health conditions. Though they are less visible than schizophrenia and bipolar disorder, they can be just as disabling. Anxiety disorders affect up to 13.3% of people in the United States, making it the most common group of mental diseases. The Epidemiological Catchments Area study, which took place around 26 years ago, was the first to disclose the scope of their occurrence. Due to their extensive occurrence, these illnesses have received increasing attention in the recent years and are being considered just as important as other syndromes such as mood and psychotic disorders. The primary care physician is often the primary assessor and treatment provider. With improvement in primary healthcare infrastructure around the world, market for anxiety disorder and depression treatment is also expected to grow.
Anxiety disorders can be blamed for lower productivity, higher morbidity and mortality rates, and an increase in alcohol and drug usage in a broad segment of the population. Therefore to treat such problems, increased attention is being paid to anxiety disorder and depression treatment. The prevalence of favourable reimbursement policies for drugs and therapies in developed economies, is expected to fuel growth during the forecast period.
However, in most cases anxiety disorder and depression treatment can be considerably expensive. Patients with no access to health insurance or good primary care facilities cannot afford such treatments because of their high cost. This can be a restraining factor for market growth in coming years.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1405
The Anxiety Disorder and Depression Treatment market report offers key insights into market scope along with emerging growth opportunities over the forecast period. The report also provides information about the competitive landscape of the global Anxiety Disorder and Depression Treatment market. The global Anxiety Disorder and Depression Treatment market is fragmented due to presence of numerous key players on a global and regional scale. Key players are focused on mergers and acquisitions, joint ventures, collaborations, partnerships, and research and development activities to expand their product portfolio and gain a robust footing in the market.
Key companies operating in the Anxiety Disorder and Depression Treatment Market and profiled in the report are:
Johnson & Johnson, Inc., Pfizer, GlaxoSmithKline plc., Lundbeck A/S, Inc., Sanofi- Aventis, Merck & Company, AstraZeneca PLC., Forest Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company among
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1405
The report provides a significant assessment of the recent market trends, revenues, segments, and key regions across the globe. The regional analysis covers major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report analyzes key regions for production and consumption patterns, import/export, market share, revenue contribution, growth rate, and supply and demand ratio for the forecast period 2024-2028. It also discusses the impact of government regulations, macro- and micro-economic factors, and economic growth of the region on overall market growth.
Drug Class Outlook (Revenue, USD Billion; 2020 – 2028)
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Antidepressant Drugs
- Tricyclic Antidepressants (TCAs)
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
- Monoamine Oxidase Inhibitors (MAOIs)
- Benzodiazepines
- Atypical Antipsychotics
- Anticonvulsants
- Beta-Blockers
- Others
Therapies Outlook (Revenue, USD Billion; 2020 – 2028)
- Electroconvulsive Therapy (ECT)
- Cognitive Behavior Therapy (CBT)
- Psychotherapy
- Deep Brain Stimulation
- Transcranial Magnetic Stimulation (TMS)
- Cranial electrotherapy stimulation (CES)
Devices Outlook (Revenue, USD Billion; 2020 – 2028)
- Cranial electrotherapy stimulator
- Fisher-Wallace stimulator market
Application Outlook (Revenue, USD Billion; 2020 – 2028)
- Phobia
- Major Depressive Disorder
- Obsessive Compulsive Disorder (OCD)
- Post-traumatic stress disorder
- Others
End-users Outlook (Revenue, USD Billion; 2020 – 2028)
- Hospitals
- Mental healthcare centers
- NGOs
- Asylums
Regional analysis covers:
- North America (U.S.A., Canada)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
To know more about the report @ https://www.reportsanddata.com/report-detail/anxiety-disorder-and-depression-treatment-market
Key Questions Answered by the Report:
- What are the key growth driving and restraining factors of the Anxiety Disorder and Depression Treatment market?
- What are key opportunities and growth prospects of the Anxiety Disorder and Depression Treatment industry is expected to witness over the forecast period?
- Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
- Which region is expected to dominate the market growth over the forecast period?
- Which segments are expected to register lucrative growth over the forecast period?
- What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1405
Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.
Explore our related report from different Publications:
Stem Cell Banking Market @ https://www.biospace.com/article/stem-cell-banking-market-size-to-reach-usd-14-48-billion-in-2028-noted-reports-and-data-/
Neuroscience Antibodies and Assays Market @ https://www.biospace.com/article/neuroscience-antibodies-and-assays-market-size-to-reach-usd-7-06-billion-in-2028-says-reports-and-data-/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
